Xconomy National

Archives

by in

Entry	Author	Date	Location
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups	Luke Timmerman	12/22/11	Seattle
Amgen Cuts 70 Washington Jobs, Hutch Spins Off Blaze Bioscience, Henney Enters the Hall, & More Seattle-Area Life Sciences News	Luke Timmerman	10/20/11	Seattle
Blaze Bioscience, Fred Hutch Spinoff with Zymo Vet at the Helm, Seeks to “Paint” Tumors	Luke Timmerman	10/18/11	Seattle
How Seattle Set Out to Create a Biotech Hub and Fostered a Global Health Nexus	Don Rule	08/08/11	Seattle
The Missing Ingredient in Today’s Biotech: Guts	Luke Timmerman	07/11/11	National
Editor’s Picks: Xconomy Seattle’s Top Stories of the First Quarter	Luke Timmerman	03/31/11	Seattle
Dendreon Makes It Official, Grabs Downtown Office and Former Zymo Lab Building	Luke Timmerman	03/01/11	Seattle
Washington’s Innovation Corridor a Key to Recovery	Chris Rivera	02/18/11	Seattle
Seattle Genetics Manager Accused of Insider Trading, Bristol Stays in Seattle, Amgen Buys BioVex, & More Seattle-Area Life Sciences News	Luke Timmerman	01/27/11	Seattle
Bristol-Myers Squibb to Stay in Seattle, Keep ZymoGenetics Workers	Luke Timmerman	01/25/11	Seattle
How ZymoGenetics Coulda Been a Contender: The Big Break That Came Too Late	Luke Timmerman	01/25/11	Seattle
Dendreon’s European Plan, Williams Heads East, Allozyne Passes Clinical Trial, & More Seattle-Area Life Sciences News	Luke Timmerman	01/13/11	Seattle
Longwood Raises First Fund, Biogen Adds Executives, Boston Scientific Acquires Intellect, & More Boston-Area Life Sciences News	Erin Kutz	01/07/11	Boston
Biogen Idec’s New R&D Boss, Doug Williams, Spurns Corner Office for a Return to Big Science	Luke Timmerman	01/06/11	Boston
Biogen Idec Nabs Doug Williams as R&D Head, Steve Holtzman as BD Chief To Fill Out Management Team	Luke Timmerman	01/05/11	Boston
Editor’s Picks: The Best of 2010 From Xconomy Seattle	Luke Timmerman	12/23/10	Seattle
ZymoGenetics CEO Exits Stage, Resolve’s Recession-Era Biotech Plan, Ikaria Pulls IPO, & More Seattle-Area Life Sciences News	Luke Timmerman	11/11/10	Seattle
Q&A With Doug Williams: Reflecting on ZymoGenetics, Looking Ahead at Seattle Biotech	Luke Timmerman	11/09/10	Seattle
ZymoGenetics CEO Doug Williams Exits the Stage, Mulls Next Free Agent Move	Luke Timmerman	11/08/10	Seattle
Immune Design Snags $212M Deal With MedImmune To Provide Vaccine Booster	Luke Timmerman	10/26/10	Seattle
Intellectual Ventures’ Latest Big Push: Turning Med-Tech Inventions Into Cash	Luke Timmerman	10/18/10	Seattle
Seattle Genetics Nails 2nd Trial, Bristol Clinches Zymo Buyout, Halosource Goes Public, & More Seattle-Area Life Sciences News	Luke Timmerman	10/14/10	Seattle
Bristol-Myers Almost Ready to Seal the Deal, Complete Takeover of ZymoGenetics	Luke Timmerman	10/08/10	Seattle
Embryonic Stem Cell Research Foe, Tracy Deisher, Seeks to Market Pro-Life Vaccines	Luke Timmerman	10/01/10	Seattle
Our Top 20 Stories of the Third Quarter: What’s Making Waves in the NW’s Tech and Biotech Sectors	Thea Chard	09/30/10	Seattle
Seattle Genetics’ Home Run, Acucela Growing Ties to Japan, Calistoga’s Wall Street Guy, & More Seattle-Area Life Sciences News	Luke Timmerman	09/30/10	Seattle
ZymoGenetics Melanoma Drug Shows Survival Data, Adding More Juice to Bristol’s Pipeline	Luke Timmerman	09/29/10	Seattle
ZymoGenetics Will Be Missed. How Seattle Biotech Can Recover and Thrive	Stewart Lyman	09/21/10	Seattle
Seattle Genetics’ Dark Horse Fails, The Future of Zymo’s Landmark, PATH Nabs Flu Vaccine Contract, & More Seattle-Area Life Sciences	Luke Timmerman	09/16/10	Seattle
Seattle Doesn’t Need a Biotech Anchor Tenant. It Needs to Be a Place Where Startups Thrive	Carl Weissman	09/14/10	Seattle
Page 1 of 6	next page »